• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

Comprehensive Overview of 4-(morpholin-4-yl)butan-2-amine dihydrochloride (CAS No. 1311315-30-6)

4-(morpholin-4-yl)butan-2-amine dihydrochloride (CAS No. 1311315-30-6) is a chemically significant compound widely utilized in pharmaceutical research and organic synthesis. This compound, characterized by its morpholine and amine functional groups, has garnered attention for its potential applications in drug development, particularly in the design of central nervous system (CNS) therapeutics. Researchers are increasingly exploring its role in modulating neurotransmitter pathways, making it a subject of interest in studies related to neurological disorders and cognitive enhancement.

The structural uniqueness of 4-(morpholin-4-yl)butan-2-amine dihydrochloride lies in its dihydrochloride salt form, which enhances solubility and stability—critical factors for in vitro and in vivo studies. Its morpholine ring contributes to improved bioavailability, a feature highly sought after in the development of bioactive molecules. Recent trends in AI-driven drug discovery have further highlighted its relevance, as computational models predict its interactions with G-protein-coupled receptors (GPCRs), a key target in modern pharmacology.

In the context of user-searched queries, this compound is often associated with topics like "morpholine derivatives in medicine", "amine-based pharmaceutical intermediates", and "CNS drug synthesis". These keywords reflect the growing demand for specialized compounds in precision medicine and personalized therapeutics. Additionally, its CAS No. 1311315-30-6 is frequently searched alongside terms such as "synthetic routes" and "analytical characterization", indicating its importance in process chemistry and quality control.

From a synthetic chemistry perspective, 4-(morpholin-4-yl)butan-2-amine dihydrochloride serves as a versatile building block for heterocyclic compounds. Its applications extend to the synthesis of small-molecule inhibitors and ligands for biological targets, aligning with the industry's shift toward fragment-based drug design. The compound's scalable production and compatibility with green chemistry principles further enhance its appeal in sustainable pharmaceutical manufacturing.

Emerging discussions in scientific forums and research publications often link this compound to advancements in neuropharmacology and metabolic engineering. For instance, its potential role in addressing neurodegenerative diseases like Alzheimer's and Parkinson's has sparked curiosity among biomedical researchers. Such intersections with high-impact research areas underscore the compound's relevance in both academic and industrial settings.

In summary, 4-(morpholin-4-yl)butan-2-amine dihydrochloride (CAS No. 1311315-30-6) represents a critical tool in modern drug discovery and chemical biology. Its multifaceted applications, coupled with its alignment with cutting-edge research trends, position it as a compound of enduring significance. As the scientific community continues to explore its potential, this molecule is poised to contribute to breakthroughs in therapeutic innovation and molecular design.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)